Skip to main content
. 2009 May 12;100(11):1765–1770. doi: 10.1038/sj.bjc.6605063

Figure 1.

Figure 1

Distribution of potential risk factors for ICC among the 160 ICC patients (A) and the 160 control cases (B). B= seropositivity for HBsAg; C= seropositivity for anti-HCV antibody; Cirr= cirrhosis; IHD= intrahepatic duct stone.